A wave of administrative changes is quietly shrinking federal research capacity and limiting public oversight, raising concerns about the integrity of scientific progress. At the same time, breakthroughs in synthetic biology and ancient DNA research highlight both the promise and the persistent inequities in who benefits from innovation. These developments underscore the urgent need for equitable distribution of scientific advances as institutional and technological forces reshape the landscape.
Bluesky
#scientific research
#public health
#technological innovation
#institutional policy
#equity
